RZISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012. (17th June 2021)

• Record Type: Journal Article
• Authors: Mattioli, V.; Crocetti, E.; Dal Maso, L.; Buzzoni, C.; Franceschi, S.; Serraino, D.; Vaccarella, S.; Ferretti, S.; Busco, S.; Fedeli, U.; Varvarà, M.; Falcini, F.; Zorzi, M.; Carrozzi, G.; Mazzucco, W.; Gasparotti, C.; Iacovacci, S.; Toffolutti, F.; Cavallo, R.; Stracci, F.; Russo, A. G.; Caldarella, A.; Rosso, S.; Musolino, A.; Mangone, L.; Casella, C.; Fusco, M.; Tagliabue, G.; Piras, D.; Tumino, R.; Guarda, L.; Dinaro, Y. M.; Piffer, S.; Pinna, P.; Mazzoleni, G.; Fanetti, A. C.;
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.104_2881
• Languages: English
• ISSNs: 0278-0232